MNOV – medicinova, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

MNOV

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/21

04:17 am

mnov

Innovative Advances in Alcohol Use Disorder Therapeutics Report 2024: In-depth Insights on 30+ Companies and 30+ Pipeline Drugs [Yahoo! Finance]

Low Report

Innovative Advances in Alcohol Use Disorder Therapeutics Report 2024: In-depth Insights on 30+ Companies and 30+ Pipeline Drugs [Yahoo! Finance]

Report

11/19

09:00 am

mnov

MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders

Medium Report

MediciNova CEO Yuichi Iwaki Provides Corporate Update in Letter to Stockholders

Report

11/15

03:07 am

mnov

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Medium Report

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Report

11/14

06:03 pm

mnov

MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver [Yahoo! Finance]

Medium Report

MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver [Yahoo! Finance]

Report

11/14

06:00 pm

mnov

MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver

Low Report

MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-001 for Triglyceride Synthesis in the Liver

Report

11/11

06:00 pm

mnov

MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis

High Report

MediciNova Given Notice of Monetary Damages Due Under Patent Settlement of Sanofi-Novartis

Report

11/7

02:04 am

mnov

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Low Report

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Report

10/30

02:07 am

mnov

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Neutral Report

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Report

10/23

07:08 pm

mnov

MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium) [Yahoo! Finance]

Low Report

Report

10/23

07:00 pm

mnov

MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium)

Neutral Report

MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast Amyotrophic Lateral Sclerosis Consortium)

Report

10/22

02:02 am

mnov

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Low Report

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Report

10/14

02:18 am

mnov

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Low Report

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Report

10/7

09:59 am

mnov

MediciNova (NASDAQ:MNOV) shareholders have endured a 73% loss from investing in the stock five years ago [Yahoo! Finance]

Low Report

MediciNova (NASDAQ:MNOV) shareholders have endured a 73% loss from investing in the stock five years ago [Yahoo! Finance]

Report

10/6

02:02 am

mnov

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Low Report

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Report

9/30

09:00 am

mnov

MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)

Low Report

MediciNova to Support NIH-Funded Expanded Access Clinical Trial to Evaluate MN166 (ibudilast) in Amyotrophic Lateral Sclerosis (ALS)

Report

9/28

02:02 am

mnov

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Medium Report

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Report

9/20

02:37 am

mnov

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

High Report

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Report

9/12

02:07 am

mnov

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

High Report

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Report

9/9

07:00 pm

mnov

MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Symposium on ALS / MND

Medium Report

MediciNova Announces Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial Accepted for Poster Presentation at the 35th International Symposium on ALS / MND

Report

9/4

02:08 am

mnov

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

High Report

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Report

9/3

07:00 pm

mnov

MediciNova Announces Acceptance of Abstract Regarding MN-166 (ibudilast) in COMBAT-ALS Clinical Trial for Presentation at the 2024 Annual NEALS (Northeast Amyotrophic Lateral Sclerosis Consortium) Meeting

High Report

Report

8/30

08:51 am

mnov

MediciNova gains after patent win for long COVID therapy [Seeking Alpha]

Medium Report

MediciNova gains after patent win for long COVID therapy [Seeking Alpha]

Report

8/29

07:00 pm

mnov

MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-166 (ibudilast) for the Post-COVID Condition

High Report

MediciNova Receives Notice of Allowance from United States Patent and Trademark Office for New Patent Covering MN-166 (ibudilast) for the Post-COVID Condition

Report

8/27

11:33 am

mnov

MediciNova (NASDAQ:MNOV) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]

Medium Report

MediciNova (NASDAQ:MNOV) Is In A Good Position To Deliver On Growth Plans [Yahoo! Finance]

Report

8/27

02:04 am

mnov

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

High Report

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.